Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Israel’s Aidoc gets third FDA nod for AI tools for radiologists

Israel’s Aidoc, which provides artificial intelligence tools for radiologists, said the U.S. Food and Drug Administration cleared the company’s product for triage of cervical spine fractures.

Read More »

RPA + AI: How Automation Can Solve Your Core Business Challenges

There are some phrases which have become commonplace in pharma over the past few years. First, that data is the ‘new lifeblood’, able to make better, faster, more reliable decisions. But how many of us have really realized this benefit in a noticeable manner?

Read More »

LabTwin’s AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API

LabTwin GmbH, the world’s first voice and AI-powered digital lab assistant, announced the company’s new open API that will connect scientists with data sources both inside and outside of the lab.

Read More »

Award-Winning Workplace Uses Complex Algorithms to Create Personalized Company Yearbooks for Every Employee

Klick Inc., a six-time-and-counting 2019 Best Workplace award recipient, is rewriting the book on employee engagement.

Read More »

FDA Approves Zebra Medical’s AI Chest X-Ray Product

Israel’s Zebra Medical Vision received approval from the U.S. Food and Drug Administration for the company’s artificial intelligence-based chest X-ray triage product.

Read More »

Future of Healthcare

I got into Healthcare six years ago and canvassed major events to gain a consensus on what the future held.

Read More »

Google Steps Up Efforts to Use Artificial Intelligence in Health Care

Artificial intelligence (AI) is increasingly seen as a tool in biopharma and life sciences to improve drug development. There is a bit of a resource lag because AI is expensive. For example, Google/Alphabet owns an AI laboratory called DeepMind. Google acquired DeepMind in 2014 for a reported $650 million. Google, as one of the largest corporations on Earth, is very interested in the use of AI and health care.

Read More »

Gilead teams up with insitro for experimental NASH treatments

Gilead Sciences Inc. will partner with privately held insitro to develop therapies for a fatty liver disease called NASH.

Read More »

Bristol-Myers Squibb and Concerto HealthAI Sign Cancer Real World Data Agreement

Bristol-Myers Squibb inked a multi-year strategic agreement with Concerto HealthAI, which focuses on oncology-specific Real-World Data and advanced AI for Real-World Evidence generation.

Read More »

Celgene, Exscientia Ink Three-Year AI Research Deal

U.K.-based Exscientia signed a three-year artificial intelligence (AI)-based drug discovery collaboration with Celgene.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom